- Q4 2023 Amicus Therapeutics Inc Earnings Call TranscriptFeb 28, 2024$12.85 (-7.75%)Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Amicus Therapeutics Inc at UBS BioPharma Conference TranscriptNov 09, 2023
- Q3 2023 Amicus Therapeutics Inc Earnings Call TranscriptNov 08, 2023$11.37 (-2.10%)Earnings
- Amicus Therapeutics Inc to Discuss the FDA Approval Call TranscriptSep 28, 2023
- Amicus Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Amicus Therapeutics Inc Earnings Call TranscriptAug 08, 2023$11.09Earnings
- Amicus Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q1 2023 Amicus Therapeutics Inc Earnings Call TranscriptMay 10, 2023$11.09Earnings
- Q4 2022 Amicus Therapeutics Inc Earnings Call TranscriptMar 01, 2023$11.09Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Q3 2022 Amicus Therapeutics Inc Earnings Call TranscriptNov 07, 2022$11.09Earnings
- Amicus Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Amicus Therapeutics Inc Earnings Call TranscriptAug 04, 2022$10.57 (+2.67%)Earnings
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Amicus Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Amicus Therapeutics Inc Earnings Call TranscriptMay 09, 2022$6.19 (-12.20%)Earnings
- Q4 2021 Amicus Therapeutics Inc Earnings Call TranscriptFeb 24, 2022$8.1 (-3.63%)Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Amicus Therapeutics Inc Earnings Call TranscriptNov 09, 2021$11.54 (-5.32%)Earnings
- Amicus Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Amicus Therapeutics Inc and ARYA Sciences Acquisition IV Corp to Announce Formation of a Next-Generation Genetic Medicine Company Call TranscriptSep 29, 2021
- Amicus Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Amicus Therapeutics Inc Earnings Call TranscriptAug 05, 2021$9.93 (+2.17%)Earnings
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Amicus Therapeutics Inc at UBS Global Healthcare Virtual Conference TranscriptMay 24, 2021
- Amicus Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 Amicus Therapeutics Inc Earnings Call TranscriptMay 10, 2021$9.41 (-0.95%)Earnings
- Q4 2020 Amicus Therapeutics Inc Earnings Call TranscriptMar 01, 2021$11.75 (-3.35%)Earnings
- Amicus Therapeutics Inc to Discuss the Topline PROPEL Results - Conference Call TranscriptFeb 11, 2021
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Amicus Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Amicus Therapeutics Inc Earnings Call TranscriptNov 05, 2020$18.24Earnings
- Amicus Therapeutics Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- Amicus Therapeutics Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Q2 2020 Amicus Therapeutics Inc Earnings Call TranscriptAug 10, 2020$10.19Earnings
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Q1 2020 Amicus Therapeutics Inc Earnings Call TranscriptMay 07, 2020$10.19Earnings
- Q4 2019 Amicus Therapeutics Inc Earnings Call TranscriptMar 02, 2020$9.88Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q3 2019 Amicus Therapeutics Inc Earnings Call TranscriptNov 11, 2019$7.81Earnings
- Amicus Therapeutics Inc Analyst Day TranscriptOct 10, 2019
- Q2 2019 Amicus Therapeutics Inc Earnings Call TranscriptAug 08, 2019$12.36Earnings
- Amicus Therapeutics Inc Presents Positive Interim Clinical Data for CLN6 Batten Disease Conference Call TranscriptAug 01, 2019
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Amicus Therapeutics Inc and the University of Pennsylvania Expansion of Gene Therapy Collaboration - Call TranscriptMay 29, 2019
- Amicus Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Amicus Therapeutics Inc Earnings Call TranscriptMay 08, 2019$13.62Earnings
- Amicus Therapeutics Inc to Discuss the Preclinical Data Presented at ASGCT - Call TranscriptApr 30, 2019
- Amicus Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 Amicus Therapeutics Inc Earnings Call TranscriptFeb 28, 2019$12.37Earnings
- Amicus Therapeutics Inc to Discuss the Clinical Pompe Disease Data and Preclinical Batten Disease Data Presented at the WORLDSymposium TranscriptFeb 07, 2019
Amicus Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Welcome everybody to the 42nd Annual JP Morgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. And I'm joined by my squad Malcolm Kuno, Priyanka Grover, and LaRhea Hall.
Our next presenting company is Amicus, and presenting on behalf of the company, we've CEO, Brad Campbell. Brad?
Thanks a lot, Anupam, JPMorgan, for hosting us. It's great to be here. It's always a great way to start the year. Everybody's been reflecting on how nice it is to have sunshine outside, a better macro environment. It's a good time to be a biotech CEO with two commercial products, and we'll talk a lot more about Amicus. Of course, I'll be making forward looking statements. As always, we refer you to our Safe Harbor provisions.
Amicus Therapeutics, we are a company that was founded on the idea that we could make next-generation therapies for people living with rare and orphan diseases. And after almost 20 years
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)